From: Over-expression of 14-3-3zeta is an early event in oral cancer
Clinicopathological Features | Total Cases | 14-3-3 zeta overall Positivity | 14-3-3 zeta Cytoplasmic Positivity | 14-3-3 zeta Cytoplasmic & Membrane Positivity | 14-3-3 zeta Cytoplasmic & Nuclear Positivity | ||||
---|---|---|---|---|---|---|---|---|---|
 | N | n | (%) | n | (%) | n | (%) | n | (%) |
OSCC | 120 | 95 | (79) | 77 | (65) | 8 | (6) | 10 | (8) |
Differentiation | Â | Â | Â | Â | Â | Â | Â | Â | Â |
WDSCC | 67 | 51 | (76) | 43 | (64) | 4 | (6) | 4 | (6) |
MDSCC | 47 | 39 | (83) | 29 | (61) | 4 | (8) | 6 | (12) |
PDSCC | 6 | 5 | (83) | 5 | (83) | 0 | Â | 0 | Â |
Tumor Stage | Â | Â | Â | Â | Â | Â | Â | Â | Â |
T1 | 20 | 17 | (85) | 15 | (75) | 1 | (5) | 1 | (5) |
T2 | 36 | 24 | (66) | 18 | (50) | 2 | (5) | 4 | (11) |
T3 | 32 | 27 | (84) | 19 | (60) | 5 | (15) | 3 | (9) |
T4 | 32 | 27 | (84) | 25 | (78) | 0 | Â | 2 | (6) |
Nodal Status | Â | Â | Â | Â | Â | Â | Â | Â | Â |
N- | 66 | 51 | (77) | 43 | (65) | 4 | (6) | 4 | (6) |
N+ | 54 | 44 | (81) | 34 | (63) | 4 | (7) | 6 | (11) |
Habits | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Non consumer | 16 | 12 | (75) | 10 | (62) | 1 | (6) | 1 | (6) |
Tobacco consumer | 104 | 83 | (80) | 67 | (64) | 7 | (7) | 9 | (9) |